FDA ISSUES EMERGENCY USE AUTHORIZATION FOR
CONVALESCENT PLASMA AS POTENTIAL PROMISING COVID-19 TREATMENT
WASHINGTON – On Aug. 23, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent…